Liu, X., Zhuang, C., Song, Y., He, P., Zheng, D., Yan, X., Zhong, X., Tian, T., Wei, B., Xie, Y. X., Chen, J., Lv, Q., Luo, T. (2025). An exploratory clinical study investigating the neoadjuvant treatment of HER2-low expressing, stage II-III breast cancer with disitamab vedotin combined with penpulimab (RCVDBCIIR005).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e12620